According to GuruFocus Insider Data, the recent chief financial officer (CFO) buys were: Antares Pharma Inc. (ATRS, Financial), Sonoma Pharmaceuticals Inc. (SNOA, Financial) and Versum Materials Inc. (VSM, Financial).
Antares Pharma CFO bought 100,000 shares
Senior Vice President and CFO Fred M. Powell bought 100,000 shares for $2.03 per share on Dec. 9. The stock price has increased by 1.48%.
Antares Pharma has a market cap of $308.470 million, and its shares were traded around $2.06. The company has a price-sales (P/S) ratio of 6.07. Over the past five years, Antares Pharma had an annual average earnings growth of 28.70%.
Antares Pharma reported revenues of $13.48 million and gross profit of $5.45 million in the third quarter while the net loss was $6.12 million. The 2015 total revenue was $45.66 million, a 72% increase from the 2014 total revenue. The 2015 gross profit was $26.2 million, a 72% increase from the 2014 gross profit. The 2015 net loss was $20.66 million.
Director Leonard S. Jacob sold 20,000 shares for $1.97 per share on Dec. 1. The stock price has increased by 4.57%.
Sonoma Pharmaceuticals CFO bought 5,000 shares
CFO Robert E. Miller bought 5,000 shares for $4.86 per share on Dec. 8. The stock price has increased by 2.06%.
Sonoma Pharmaceuticals has a market cap of $20.480 million, and its shares were traded around $4.96. The company has a P/S ratio of 1.18.
Sonoma Pharmaceuticals reported revenues of $4.12 million and gross profit of $2.08 million in the third quarter while the net loss was $1.95 million. The 2016 total revenue was $15.08 million, a 9% increase from the 2015 total revenue. The 2016 gross profit was $7.21 million, a 1% decrease from the 2015 gross profit. The 2016 net loss was $10.16 million.
CEO James J. Schutz bought 1,000 shares for $4.88 per share on Dec. 8. The stock price has increased by 1.64%.
Versum Materials CFO bought 8,000 shares
Senior Vice President and CFO George G. Bitto bought 8,000 shares for $24.72 per share on Dec. 5. The stock price has increased by 12.74%.
Versum Materials has a market cap of $3.05 billion, and its shares were traded around $27.87. The company has a price-earnings (P/E) ratio of 1.46 and P/S ratio of 4.13.
Controller and Principal Accounting Officer Jessica D. Feather-Bowman bought 2,000 shares for $26.7 per share on Dec. 7. The stock price has increased by 4.38%.
Director Seifi Ghasemi bought 20,000 shares for $24.66 per share on Dec. 5. The stock price has increased by 13.02%.
Director Jacques M. Croisetiere bought 4,000 shares for $24.62 per share on Dec. 5. The stock price has increased by 13.2%.
Disclosure: None.
Start a free seven-day trial of Premium Membership to GuruFocus.
